Logo-jre

Mini-Review

1. Administration of baclofen in end-stage renal disease
Fatemeh Hayati, Mohammad Amin Nasouti*, Shokhouh Shayanpour, Shahla Ahmadi Halili
J Ren Endocrinol. 2017;3: e02 | Published on: 2017 Jan 06.
Article
PDF
XML
Cited By:
Editorial

2. Renal injury by administration of proton pump inhibitors
Masoud Amiri*
J Ren Endocrinol. 2017;3: e06 | Published on: 2017 Apr 09.
Article
PDF
XML
Cited By:
Epidemiology and Prevention

3. Fetuin-A in kidney disease
Marziyeh Akbari, Hashem Nayeri*, Hamid Nasri
J Ren Endocrinol. 2018;4: e19 | Published on: 2018 Jul 08.
Article
PDF
XML
Cited By:
Original Article

4. Cholecalciferol therapy; is it the gold standard for vitamin D deficiency and mineral disorders in hemodialysis?
Mouna Jerbi*, Hiba Ghabi, Hanene Gaied, Fathi Ben Hmida, Raja Aoudia, Rim Goucha, Taieb Ben Abdallah
J Ren Endocrinol. 2021;7: e09 | Published on: 2020 Nov 20. doi: 10.34172/jre.2021.09
Article
PDF
XML
Cited By:
0
Original Article

5. The relation between vitamin D status and anemia in patients with end stage renal disease on regular hemodialysis
Essam Nour el Din Afifi, Ahmed Mohamed Tawfik, Essam Eldin Rashed Saeed Abdulkhalek, Lina Essam Khedr* ORCID
J Ren Endocrinol. 2021;7: e15 | Published on: 2021 Jun 05. doi: 10.34172/jre.2021.15
Article
PDF
XML
Cited By:
0
Review

6. Therapeutic effects of curcumin on kidney disease; an updated review of the current knowledge
Lillian Saberian ORCID, Niloufar Alimohammadi ORCID, Farzad Koosha ORCID, Hedayat Vali Rahvard ORCID, Khadijeh Ahmadi ORCID, Hamid Reza Jahantigh ORCID, Tella Sadighpour* ORCID
J Ren Endocrinol. 2022;8: e23063 | Published on: 2022 Dec 20. doi: 10.34172/jre.2022.23063
Article
PDF
XML
Cited By: